CMS Open Payments · Program Year 2024
Bioprotect Medical, Inc.
Bioprotect Medical, Inc. reported $165,604.75 across General Payments, Research, and Ownership to 954 physicians and teaching hospitals across 955 transactions.
- $165.6K Below-median payer
- All-tracks total
- 955 Above-median volume
- Transactions
- 954 Above-median reach
- Recipients
- #1053
- of 1,925 companies
Bioprotect Medical, Inc. reported $165,604.75 across all CMS Open Payments tracks (General + Research + Ownership) to 954 physicians and teaching hospitals in Program Year 2024 - ranking #1053 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $136,534.75, averaging $173.59 per recipient.
How Bioprotect Medical, Inc.'s $165.6K all-tracks total breaks down
Bioprotect Medical, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
24/100
Total payments
F
11/100
Transaction volume
F
17/100
Physician reach
F
17/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer bioprotect-medical-inc Bioprotect Medical, Inc.
$165.6K · #1053/1,925 · 0.0% industry · PY2024
- TOT $165.6K
- RANK #1053
- SHARE 0.0%
- TXN 955
- RCP 954
- CAT 4
- GEN $136.5K
- TOP1 26.7%
- PY 2024
Volume peers
Nearest volume peer: B. Braun Melsungen AG ($165.4K)
Bioprotect Medical, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Bioprotect Medical, Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Bioprotect Medical, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
Of the 4 general-payment categories charted below, "Food and Beverage" is the largest at $56.9K across 925 transactions, 41.6% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Food and Beverage" leads Bioprotect Medical, Inc.'s 4-category general-payment breakdown at $56.9K, 41.6% of the reported total.
Bioprotect Medical, Inc. reports 4 general-payment categories - the top three are Food and Beverage (41.6%), Compensation for Services Other Than Consulting (35.7%), and Consulting Fee (15.3%). The remaining 1 category make up 7.3% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Bioprotect Medical, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $56.9K | 925 | 41.6% |
| Compensation for Services Other Than Consulting | $48.7K | 14 | 35.7% |
| Consulting Fee | $20.9K | 8 | 15.3% |
| Travel and Lodging | $10.0K | 7 | 7.3% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $73,347.45 (53.7%) of $136,534.75 in this company's General Payments records across 616 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Bioprotect Medical, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Shawn H Zimberg
$36,407.47 across 22 reported transactions
- 2
Daniel Kim
$21,523.72 across 28 reported transactions
- 3
Jonathan D Tward
$6,484.31 across 15 reported transactions
- 4
Steven E Finkelstein
$5,934.95 across 6 reported transactions
- 5
Aaron D Berger
$2,997.00 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Bioprotect Medical, Inc.'s spend rank (#1053 of 1,925, bottom 45% by spend) and concentration rank (#1,020 of 1,838, bottom 45% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- NeuroLogica Corporation, a subsidiary of Samsung Electronics Co., Ltd. : $273.1K total payments, HHI 1042
- PolyMedics Innovations Inc. : $62.1K total payments, HHI 1036
- Qiagen, LLC : $659.8K total payments, HHI 1034
- Seigla Medical, Inc. : $1.1K total payments, HHI 1032
- Zimmer Biomet Holdings, Inc. : $83.9M total payments, HHI 1031
- Recor Medical Inc : $244.1K total payments, HHI 1026
- Bioprotect Medical, Inc. (this company) : $136.5K total payments, HHI 1025
- I/O Urology Corp. : $2.1K total payments, HHI 1025
- Cardinal Health 200 LLC : $63.8K total payments, HHI 1024
- Genesys Orthopedics Systems, L.L.C. : $837.2K total payments, HHI 1023
- Procyrion, Inc. : $53.4K total payments, HHI 1019
- Lupin Inc. : $30.4K total payments, HHI 1015
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Bioprotect Medical, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Bioprotect Medical, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Bioprotect Medical, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
SweetBio, Inc.
Gotham Surgical Solutions & Devices, Inc.
BK Medical Holding Company Inc.
Resmed Corp
Lumendi LLC
Put this to use
Bioprotect Medical, Inc. ranks #1053 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Bioprotect Medical, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.